Showing results (941-950 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|June 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safetyThomas Zeyen, Antonia Treiber, Matthias Schneider, et al.
Neuro-Oncology Advances|June 27, 2025
Molecular alterations in IDH-mutant astrocytoma: A multi-institutional retrospective studyKeng Lam, Hanim I Ozkizilkaya, Denái R Milton, et al.
Neuro-Oncology Advances|June 27, 2025
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapyShivani Chiranth, Vincent Fougner, Ib Jarle Christensen, et al.
Neuro-Oncology Advances|June 27, 2025
Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progressionLouis Cappelli, Allison Kayne, Jennifer Newman, et al.
Neuro-Oncology Advances|June 26, 2025
Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma modelAlex Shimura Yamashita, Marina da Costa Rosa, Gregory J Riggins
Neuro-Oncology Advances|June 30, 2025
Survivorship from pediatric and adult brain tumors: The 2024 Brain Tumor Epidemiology Consortium meeting reportScott L Coven, Roberta McKean-Cowdin, Michael E Scheurer, et al.
Neuro-Oncology Advances|September 11, 2025
Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppressionBhairavy J Puviindran, Shannon Wallace, Katayoun Ayasoufi, et al.
Neuro-Oncology Advances|September 11, 2025
Immunologic specificity in glioblastoma: Antigen discovery and translational implicationsCameron M Hill, Anthony Z Wang, Brian Hsueh, et al.
Neuro-Oncology Advances|February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findingsNicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Pageof 138